Important Coronavirus (COVID-19) Service Update

Refrigerated Medicines
Fast International Shipping
Payment On Delivery
Licensed Pharmacy Supplies

Mektovi (Binimetinib)

Brand Options

Brand Name : Mektovi

Marketing Authorization Holder : Pierre Fabre

Prescription Required

 
 
No Generic Medicine available for this medicine.

Product Details

Mektovi is used to treat skin cancer (melanoma) in adults in combination with Braftovi (containing encorafenib).  This combination may slow down or stop cancer growth.

Mektovi is recommended at a dose of 90mg daily, as 45 mg (three 15 mg tablets) twice daily (12 hours apart).  In order to manage adverse reactions, dose reduction, interruption of therapy or treatment stoppage be required.



Image Image Image Image